SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,908,366 | -42.9% | 607,760 | -10.9% | 0.15% | -46.1% |
Q3 2022 | $3,343,000 | +3.7% | 682,300 | -12.4% | 0.28% | +4.0% |
Q2 2022 | $3,224,000 | -35.5% | 778,769 | -9.5% | 0.27% | -30.4% |
Q1 2022 | $5,001,000 | -56.7% | 860,702 | -44.1% | 0.39% | -46.8% |
Q4 2021 | $11,550,000 | -9.1% | 1,539,994 | +9.2% | 0.74% | -6.6% |
Q3 2021 | $12,702,000 | -12.1% | 1,409,736 | +16.8% | 0.79% | +7.6% |
Q2 2021 | $14,447,000 | +35.9% | 1,206,941 | +42.3% | 0.73% | +4.0% |
Q1 2021 | $10,631,000 | – | 848,429 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |